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Abstract
The ethyl acetate fraction from ethanolic extract of Wedelia trilobata (L.) leaves displayed wound healing properties.
The ethyl acetate fraction was further subjected to bioassay-guided fractionation which afforded isolation of grandiflorenic
acid which requires further investigation to prove its wound healing potential. The grandiflorenic acid from leaves of Wedelia
trilobata was assessed for its possible activity on BJ human fibroblast and HaCaT keratinocytes proliferation, and effect on
in vitro scratch assay,  collagen content, TGF-2  levels, and nitric oxide, TNF- and IL-1 determination using Raw 264.7
cells. Grandiflorenic acid (2.5µg/mL) produced percentage viability of BJ human fibroblast, and HaCaT keratinocytes 116, and
106% respectively. Grandiflorenic acid (2.5 µg/mL) induced a 100% migration rate in the in vitro scratch assay and the
collagen content was increased to 171.2 µg/mL compared to the control (61.1µg/mL) with BJ human fibroblast. Grandiflorenic
acid (2.5µg/mL) neither produced any significant increase in TGF-2 levels of HaCaT keratinocytes cells nor induced
migration of HaCaT cells in the in vitro scratch assay. The present study provides scientific evidence that grandiflorenic acid
has potential wound healing activity due to combination of fibroblast stimulation and inhibiting prolonging inflammatory
phase of wound healing evident by reduced levels of inflammatory cytokines from macrophage Raw 264.7 cells.
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1. Introduction
Studies on the traditional use of medicines are recog-
nized  as  a  way  to  learn  about  potential  future  medicines.
Researchers have identified 122 compounds used in main-
stream medicine that were derived from “ethnomedical” plant
sources and 80% of these compounds were used in the same
or closely related manner as for their traditional ethnomedical
use (Fabricant and Farnsworth 2001). Plants have evolved an
ability to synthesize chemical compounds to defend them-
selves against attack from a wide variety of predators such as
insects and fungi. By chance, some of these compounds,
whilst  being  toxic  to  plant  predators,  turn  out  to  have
beneficial effects when used to treat human diseases. Such
secondary metabolites are highly varied in structure, usually
aromatic in nature. Most of them are phenols or their oxygen-
substituted derivatives (Lai and Roy, 2004; Tapsell et al.,
2006).
Plants have an immense potential for the management
and treatment of wounds. A large number of plants have been
used,  by  tribal  and  folklore,  in  many  countries  for  the
treatment of wounds and burns. The presence of various
health  sustaining  constituents  in  plants  has  attracted
scientists to examine these plants with a view to determine
potential wound-healing properties (Nayak and Pinto-Pereira,
2006). The medicinal value of these plants lies in their bio-
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active  phytochemical  constituents  that  produce  definite
physiological actions on the human body (Akinmoladun et
al., 2007). These constituents include various members of
chemical families like alkaloids, essential oils, flavonoids,
tannins,  terpenoids,  saponins,  and  phenolic  compounds
(Edeoga et al., 2005). Wedelia trilobata (L.) Hitchc (Asteraceae)
commonly called creeping daisy, is a creeping herb, native to
the tropics of Central America and has naturalized in many
wet tropical areas like West Indies, Hawaii, India, Burma,
China, Japan, Ceylon, especially at low altitude (USDA-GRIN,
2008; Shanmugam et al., 2011). The leaves or aerial parts of
this plant are used in traditional medicine in Caribbean and
Central America for backache, muscle cramp, rheumatism,
stubborn wounds, sores, swelling, and arthritic painful joints
(Arvigo and Balik, 1993; Coe and Anderson, 1996). The ethyl
acetate fraction from ethanolic extract of W. trilobata leaves
displayed antibacterial and fibroblast stimulatory activities
thereby  suggesting  potential  wound-healing  properties
(Balekar et al., 2012a). The ethyl acetate fraction was further
subjected to bioassay-guided fractionation which afforded
isolation of grandiflorenic acid (ent-kaura-9(11), 16-dien-19-
oic acid) which showed antibacterial, stimulation of fibroblast
growth  and  protective  effect  against  hydrogen  peroxide
induced injury (Balekar et al., 2012b). These activities could
play some role in its effect on tissue repair. Therefore, the
aim of the present study was to evaluate activity of grandi-
florenic  acid  using  in  vitro  cell  culture  models  of  dermal
fibroblasts, epidermal keratinocytes and macrophage that
would influence management of wound infections.
2. Materials and Methods
2.1 Cell lines, chemicals and biochemicals
The BJ human skin fibroblast cells were obtained
from ATCC CRL-2522, Rockville, MD, USA, Raw 264.7,
macrophage  cells  were  procured  from  ATCC  CRL-2278,
Rockville, MD, USA, and human keratinocytes HaCaT cells
from CLS-Cell lines services, Eppelheim, Germany.
All the solvents, chemicals and biochemicals used
were of analytical grade.
2.2 The grandiflorenic acid (ent-kaura-9(11), 16-dien-19-
oic acid) was isolated from leaves of W. trilobata (Balekar
et al., 2012b), and was used into this investigation without
further re-purification.
2.3 In vitro assays relevant to wound healing
2.3.1 Cytotoxicity assay and soluble collagen production
using BJ human skin fibroblast cells
Cytotoxicity was evaluated by the method previously
reported by Balekar et al. (2012a). The BJ human skin fibro-
blast cells at a concentration of 2×10
4 cells/ mL were seeded
into a 96-well plate in complete MEM containing 10% FBS
and antibiotics (100 U/mL penicillin and 100 U/mL strepto-
mycin), under 5% CO2 at 37ºC. After 24 h, the culture medium
was  replaced  by  fresh  medium.  The  stock  solution  of
grandiflorenic acid, (100 mg/mL in DMSO), filtered through
a 0.22 µm membrane filter was further diluted to 1 mg/mL with
phosphate buffered saline (PBS) and further dilutions were
made in DMEM to achieve a final concentration in each well
of 10-0.08 µg/mL of grandiflorenic acid. The cells were treated
with DMEM medium containing dimethyl sulfoxide (0.1%).
Cells without grandiflorenic acid served as negative controls
and Proteoglycan-IPC (Ichimaru Pharcos Co. Ltd., Gifu,
Japan)  (10,  5  and  2.5  µg/mL)  solution  of  proteoglycan
extracted from nasal cartilage of Oncorhynus keta (Salmon)
having property like epidermal growth factor was used as a
positive control.  After incubation for 24 h at 37ºC with 5%
CO2, the supernatants were collected and the cells were then
treated with 100 µL of freshly prepared media along with 50
µL of 3- (4,5-dimethylthiazolyl)-2,5-diphenyltetrazolium
bromide (MTT) solution (5 mg/mL) and incubated at 37ºC for
4 h. Then, the medium containing MTT was removed and
100 µL of DMSO was added. The absorbance was determined
by a microplate reader (Biohit 830, Biohit
®, Helsinki, Finland)
at a wavelength of 570 nm. The percentage of cell viability
was calculated and compared to a negative control.
The  total  amount  of  soluble  collagen  type  I  was
assayed in the supernatant using the Sircol
® collagen assay
kit (Bicolor Life Science Assays, Northern Ireland, UK). Briefly,
100 µL of experimental supernatant was mixed with 1 mL of
dye solution at room temperature for 30 min. Then the
samples were centrifuged at 15,000 g for 10 min to form a
pellet of collagen. The supernatant was removed and the
produced soluble collagen was dissolved in 1 mL of alkali
reagent. The resultant alkali reagent solutions were transferred
to a 96-well plate and assayed by a microplate reader (Biohit
830, Biohit
®, Helsinki, Finland) at a wavelength of 540 nm.
The amount of collagen was calculated based on a standard
curve  of  soluble  collagen  (bovine  skin  collagen  type  I
standard from American disease-free animals).
2.3.2 Cytotoxicity assay and determination of TGF-2 using
Keratinocytes cells
Cytotoxicity was evaluated by the method previously
reported by Amjad et al (2007). The keratinocytes HaCaT
cells  at a concentration of 2×10
4 cells/ mL were seeded into
a 96- well plate in complete DMEM containing 10% FBS and
antibiotics (100 U/mL penicillin and 100 U/mL streptomycin),
under 5% CO2 at 37ºC. After 24 h, the culture medium was
replaced with fresh medium. The stock solution of grandi-
florenic acid (100 mg/mL in DMSO), filtered through a 0.22
µm membrane filter, was further diluted to 1 mg/mL with
phosphate buffer saline (PBS) and further dilutions were made
in DMEM to achieve a final concentration of  10-0.08 µg/mL
of grandiflorenic acid in DMEM. The cells were treated with
DMEM medium containing DMSO (0.1%). Cells without
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tion for 24 h at 37ºC with 5% CO2, the supernatants were
collected and assayed for human TGF-2 using ELISA assay
kit (R & D Systems, Minneapolis, MN, USA) and the cells
were treated with MTT for cytotoxicity determination. The
percentage of cell viability was calculated and compared to
a negative control.
2.3.3 In vitro scratch assay using BJ human skin fibroblast
and keratinocytes HaCaT cells
The fibroblast and keratinocytes cells (5×10
4 cells/
mL) in MEM and DMEM containing 10% FBS were seeded
in a 6 well plate. Once the confluent monolayer was formed,
a linear scratch was generated in the monolayer with a sterile
pipette tip. The cellular debris was removed by washing with
phosphate buffer saline (PBS) and replaced with 2 mL of
MEM containing grandiflorenic acid (2.5, 1.25 0.625 µg/mL).
Proteoglycan-IPC  (10  and  5  µg/mL)  served  as  a  positive
control, and MEM without sample served as a negative
control for BJ human fibroblast and grandiflorenic acid (2.5,
1.25, 0.625 µg/mL) and DMEM without sample served as a
negative control for keratinocyte HaCaT. Photographs were
taken  at  a  10x  magnification  using  a  light  microscope
(Olympus CK2, Japan) on day 0,  then plates were incubated
at  37ºC with 5% CO2 and photographs were taken at days
1 and 2. The images acquired for each sample were further
analyzed quantitatively using computing software (ImageJ
1.42q/Java1.6.0_10). By comparing the images from day 0 to 2,
the distance of each scratch closure was determined and the
percentage migration rate was calculated. In each well two
parallel scratches were made and on each scratch six points
were considered. Average of left scratch and right scratch
were taken separately. Percent migration was calculated for
left scratch and then right scratch using
% Migration rate =
Average distance between scratch (Day 0) - Average distance
100
Average distance between scratch (Day 0)

Samples  were  in  quadruplicate.  Percent  rate  of  migration
obtained from all four wells were averaged and recorded
(Balekar et al., 2012a).
2.3.4 Cytotoxicity assay, and nitric oxide using RAW 264.7
cells
The cytotoxicity and nitric oxide was determined using
method described by Chuealee et al (2011). The Raw 264.7
cells in DMEM medium containing 10% FBS, were seeded at
an initial concentration of 1×10
4/ml into 96-well plates and
incubated at 37ºC with 5% CO2. After 24 h, the culture medium
was replaced with fresh medium. The stock solution of
grandiflorenic acid (100 mg/mL in DMSO), filtered through
a 0.22 µm membrane filter, was further diluted to 1 mg/mL
with phosphate buffer saline (PBS) and further dilutions were
made in DMEM to achieve a final concentration of  10-0.08
µg/mL of grandiflorenic acid in DMEM. Cells without drug
sample served as negative controls. After incubation for 24 h
at 37ºC with 5% CO2, the supernatants were collected and
assayed for  nitric oxide by the Griess reaction and the cells
were treated with MTT for cytotoxicity determination. For
nitric oxide, 100 µl Griess reagent (1% N-(1-napthyl)-ethylene-
diamine  dihydrochloride  and  1%  sulfanilamide  in  2.5%
phosphoric acid) was mixed with 50 µl of experimental cell
supernatant  and  absorbance  was  recorded  at  540  nm  and
quantification was done.
2.3.5 TNF- and IL-1 determination using RAW 264.7
cells.
The TNF- and IL-1 was determined using the
method described by Chuealee et al (2011). The Raw 264.7
cells in DMEM medium containing 10% FBS, were seeded at
an initial concentration of 1×10
4/ml into 96 well plates and
incubated at 37ºC with 5% CO2. After 24 h, the culture medium
was replaced with fresh medium. The cells were then treated
with grandiflorenic acid (2.5-0.156 µg/mL). Cells with DMEM
medium served as negative controls. After incubation for 24 h
at 37ºC with 5% CO2, the supernatants were collected and
assayed  for  TNF-,  and  IL-1  using  rat  ELISA  assay  kit
(R & D systems, MN, USA). The minimal detectable doses of
TNF-, IL-1 were approximately 5.0 pg/ml and 3.0 pg/ml,
respectively. All experiments were done in quadruplicate.
The TNF- reaction was quantitatively recorded at 450 nm,
based on standard curve of 14-875 pg/ml. The same wave-
length was used to record IL-1 levels, based on standard
curve of 12.5 - 800 pg/ml. Lipopolysaccharide (LPS) from
E. coli was used as positive control (15.65-500 ng/ml).
2.3.6  In vitro hemolysis assay
Lysis of human red blood cells (RBC) was evaluated
as described by Chuealee et al (2011). Briefly, erythrocytes
(Blood Bank, Department of Pathology, Faculty of Medicine,
Songklanagarind Hospital, PSU, Thailand) were isolated from
fresh  human  blood,  washed  three  times  with  phosphate
buffered saline solution (PBS) and centrifuged at 1500g for
5 min. The stock solution of grandiflorenic acid (100 mg/ml
in DMSO) was further diluted with PBS to 1 mg/ml. The
grandiflorenic  acid  was  then  added  to  the  suspended
erythrocytes and the suspension diluted with PBS to give
final grandiflorenic acid concentrations in the range of 1-8
µg/ml and a final hematocrit of 1%. It was then incubated at
37°C for 0.5, 3, 6 and 24h. The unlysed cells were removed by
centrifugation at 3000g for 5 min and the hemoglobin in the
supernatant  was  determined  at  absorbance  540  nm.  The
positive  control  was  1%  Triton  X-100  (Sigma-Aldrich,
Steinheim, Germany) and negative control was phosphate
buffer saline. Hemolysis was reported as a percentage of the
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(Absorbance of sample - Absorbance of negative control)
100
(Absorbance of positive control - Absorbance of negative control)

2.4 Statistical analysis of data
Data are expressed as a mean ± S.D. Statistical evalua-
tion was carried out using one-way ANOVA followed by
Tukey’s  test  using  “Graphpad  Instat”  version  3.00  for
Windows 95, Graphpad software, San Diego California USA.
The  values  of  p<0.05  were  considered  to  be  statistically
significant. All experiments were done in quadruplicate.
3. Results
3.1 Chemical elucidation of the isolated compound
The isolated compound was identified as Grandi-
florenic acid (ent-kaura-9(11),16-dien-19-oic acid) (Figure 1)
by FT-IR, 
1H-NMR, 
13C NMR spectra (Balekar et al., 2012b).
3.2 Influence of grandiflorenic acid on cell viability and
collagen content using L929 fibroblast
The grandiflorenic acid at 10-0.08 µg/mL produced
cell  viability  above  97%  (Figure 2).  The  dose  range  of
grandiflorenic acid (2.5-0.08 µg/mL) produced cell viabilities
in the range of 117-100% (Figure 2). The ent-kaura-9(11), 16-
dien-19-oic acid was found in W. trilobata. Cells treated with
0.1% DMSO showed no toxicity with cell viability to 100%.
This  indicated  that  this  concentration  of  DMSO  had  no
significant toxic effects on cells. Proteoglycan (10, 5 and 2.5
µg/mL) used as positive control exhibited percent viability
100, 102 and 101%, respectively. The percent viability with
grandiflorenic acid (2.5 µg/mL) was 116%, higher than that
with proteoglycan (2.5 µg/mL) which was 101%. The results
showed that collagen type I production in BJ fibroblast cells
increased significantly after treatment with grandiflorenic
acid at concentrations of 2.5, 1.25 and 0.625 µg/mL (p<0.01) as
compared to the control. Collagen production by fibroblast
cells when treated with proteoglycan (10, 5 and 2.5 µg/mL)
was 181.7, 191.2, and 212 µg/mL (Table 1). The grandiflorenic
Figure 1. Chemical structure of grandiflorenic acid (ent-kaura-9(11),
16-dien-19-oic acid) from leaves of W. trilobata.
Figure 2. Percentage of BJ human skin fibroblast cells surviving
after 24 h incubation at 37°C with 5% CO2 and treated
with grandiflorenic acid and proteoglycan-IPC at various
concentrations. Data expressed as mean±s.d., (n= 4).
*p<0.01 vs negative control group (one-way ANOVA,
followed by Tukey’s test).
Table 1. Collagen type-I production in the BJ human fibroblast cell line when
treated with various concentrations of grandiflorenic acid from the
leaves of W. trilobata.
            Treatment Conc (µg/mL) Collagen production (µg/mL)
Negative control - 61.1 ± 6.7
Grandiflorenic acid (µg/mL) 0.08 58.2 ± 5.7
0.16 61.8 ± 6.2
0.31 73.6 ± 6.5
0.63 125.8 ± 5.6
*
1.25 158.9 ± 5.8
*
2.5 171.2 ± 5.4
*
5 122.2 ± 5.0
*
10 91.1 ± 4.8
*
Proteoglycan 2.5 181.7 ± 5.8
*
(Positive control) 5 191.2 ± 5.3
*
10 212.0 ± 6.5
*
Values are mean
 ± S.D., (n=4); 
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acid (2.5 µg/mL) produced collagen 171.2 µg/mL, which was
comparable to the collagen produced by proteoglycan (2.5
µg/mL) treatment.
3.3 Influence  of  grandiflorenic  acid  on  cell  viability  and
TGF-2 levels using human keratinocytes HaCaT
The grandiflorenic acid (10-0.08 µg/mL) produced cell
viability in the range of 89-98%. The dose range of grandi-
florenic acid (2.5-0.31 µg/mL) produced cell viabilities in the
range of 106-103%. This data indicated better viability of
keratinocytes at the concentration range used in this study.
The level of TGF-2 produced by HaCaT keratinocytes after
exposure to grandiflorenic acid at a concentration of 10-0.08
µg/mL  was  40-43  pg/ml,  which  was  similar  to  the  level
produced by control group (43 pg/mL). No significant changes
were observed in TGF-2 levels.
3.4 Effect of grandiflorenic acid on in vitro scratch assay
using BJ human fibroblast and keratinocytes HaCaT
cells
The grandiflorenic acid was evaluated for changing
the rate of migration of the BJ fibroblast cells and keratino-
cytes  HaCaT.  The  cellular  proliferation  and  migration  of
fibroblasts was studied on day 0, 1 and 2 (Figure 4 and Table
2).  The presence of grandiflorenic acid (2.5, 1.25, 0.625 µg/
mL) caused an increased number of fibroblasts in the denuded
area when comparing either days 1 or 2 to the control (p<
0.01). As shown in Figure 4 an incubation time of two days
resulted  in  the  highest  number  of  migrated  cells  in  the
denuded area.
The length between the scratch mark edges with
grandiflorenic acid (2.5 µg/mL) was 346.5±13.2 µm (day 0)
and  there  was  closure  of  the  gap  on  day  1.  The  length
between the scratch mark edges with negative control was
336.3±8.5µm on day 0, 166±9.6 µm on day1 and 73.8±4.6
µm on day 2,  and with proteoglycan (5 and 10 µg/mL) was
322.5±10 and 345.8±6.6 µm (day 0), and complete closure of
gap on day 1. The grandiflorenic acid (2.5 µg/mL) showed
a 100% migration rate on day 1 while dose of 1.25 µg/mL
showed 72% on day 1 and on day 2 complete closure of gap
Table 2. Effect of the grandiflorenic acid from the leaves of W. trilobata on in vitro scratch assay using BJ human fibroblast.
          Length between the scratch (µm)            % Migration rate of cells
Day 0 Day 1 Day 2 Day 1 Day 2
Negative control - 336.3 ± 8.5    166 ± 9.6* 73.8± 4.6* 50.6 ± 2.9 78.1 ± 1.4
Grandiflorenic acid 0.625       336 ± 10.7 111.3± 3.1*    56 ± 7.0* 66.5 ± 0.9*  83.3 ± 2.1*
1.25 331.8 ± 9.0   95.8 ± 6.5* CC 71.5 ± 1.9* 100*
2.5   346.5 ± 13.2 LC CC 100
* 100*
Proteoglycan(Positive control) 5   322.5 ± 10.0 CC CC 100
* 100*
10 345.8 ± 6.6 CC CC 100
* 100*
Values are mean
 ± S.D., (n=4); *P < 0.01 vs negative control group; LC: loosely closed; CC: complete closure of the scratch
Dose
(µg/mL)
Treatment
Figure 3. Percentage of keratinocytes HaCaT cells surviving after 24
h incubation at 37 °C with 5% CO2 and treated with
grandiflorenic acid at various concentrations. Data ex-
pressed as mean ± s.d., (n= 4).
Figure 4. Measurement of cell migration in the in vitro scratch
assay. A BJ human skin fibroblast layer subjected to
scratch and treated with negative control (A), grandi-
florenic acid (2.5 g/mL) (B), and Proteoglycan (10 g/
mL) (C). Images captured at 10x magnification using a
light microscope at day 0, 1 and 2 after incubation. The
rate of migration was measured by quantifying the total
distance that the cells moved from the edge of the scratch
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resulting to 100% migration rate. Proteoglycan (5 and 10 µg/
mL) showed a 100% migration rate on day 1. Migration rate
of grandiflorenic acid and proteoglycan was found to be two
times higher than that of the negative control. The grandi-
florenic  acid  and  proteoglycan  treatment  restored  the  BJ
fibroblast cells to a confluent or near confluent state within
24 h, in contrast to the negative control (more than 48 h).
The presence of grandiflorenic acid (5, 2.5, and 1.25
µg/mL) did not cause an increased number of keratinocytes
in the denuded area when comparing either days 1 or 2 to the
negative control (Table 3). As shown in Figure 5 incubation
time of two days did not result in the migration of the cells
in the denuded area. The grandiflorenic acid (2.5 µg/mL)
showed a 19.7% and control group 14.8% migration rate on
day 2.  The  results  indicating  no  significant  activity  of
grandiflorenic acid on keratinocytes proliferation.
3.5 Effect of grandiflorenic acid on cell viability, and nitric
oxide using Raw 264.7 cells
The viability of Raw 264.7 cell lines was estimated
after being challenged with grandiflorenic acid (10-0.08 µg/
ml). The viability of Raw 264.7 cells was found to be more
than 90% (Figure 6) at concentration between 2.5-0.08 µg/ml.
Nitric oxide is usually produced during inflammatory condi-
tions such as wound healing by the inducible isoform of the
enzyme NO synthase. Production of NO by Raw 264.7 cells
exposed  to  grandiflorenic  acid  could  not  be  detected  in
culture supernatants.
3.6 Effect of grandiflorenic acid on TNF- and IL-1 using
Raw 264.7 cells
Figures 7 and 8 represent the amounts of IL-1 and
TNF- released from the Raw 264.7 cells after grandiflorenic
acid activation. The level of IL-1 produced by Raw 264.7
cells after exposure to grandiflorenic acid at a concentration
of 2.5-0.16 µg/ml was 6.5-7.5 pg/ml, whereas the levels of
TNF- produced by Raw  264.7 cells  after exposure to
grandiflorenic acid was in range of 50-32 pg/ml. The LPS-
activated Raw 264.7 cells produced inflammatory cytokines
at significantly higher levels than Raw 264.7 cells activated
by grandiflorenic acid (p<0.01). The production of IL-1 and
Table 3. Effect of the grandiflorenic acid from the leaves of W. trilobata on in vitro scratch assay using keratinocytes HaCaT.
            Length between the scratch (µm)            % Migration rate of cells
Day 0 Day 1 Day 2 Day 1 Day 2
Negative control - 374.8 ± 3.6  353.5 ± 6.4* 319.3 ± 9.9* 5.7 ± 1.7 14.8 ± 2.7
Grandiflorenic acid 0.625     374.0± 10.3 355.0 ±7.5* 333.8 ± 7.3* 5.1 ± 2.0 10.8 ± 1.9
1.25     376.8± 11.8 356.8 ± 8.3*   322.3 ± 13.4* 5.3 ± 2.2 14.5 ± 3.6
2.5 375.0 ± 9.3    356.0 ± 13.2*   301.0 ± 11.8* 5.1 ± 3.5 19.7± 3.1
Values are mean
 ± S.D., (n=4); *p<0.01 vs negative control group
Dose
(µg/mL)
Treatment
Figure 5. Measurement of cell migration in the in vitro scratch assay.
The human keratinocytes HaCaT subjected to scratch and
treated with negative control (A), and grandiflorenic acid
(B). Images captured at 10x magnification using a light
microscope at day 0, 1 and 2 after incubation. The rate of
migration was measured by quantifying the total distance
that the cells moved from the edge of the scratch towards
the center.
Figure 6. Percentage of Raw 264.7 cells surviving after 24 h incuba-
tion at 37°C with 5% CO2 and treated with grandiflorenic
acid at various concentrations. Data expressed as mean ±
s.d., (n = 4).543 N. Balekar et al. / Songklanakarin J. Sci. Technol. 35 (5), 537-546, 2013
TNF- by Raw 264.7 cells exposed to grandiflorenic acid
could be detected at a very low level, while very high levels
of IL-1 and TNF- were generated from Raw 264.7 cells
exposed to LPS.
3.7 Effect of grandiflorenic acid on hemolysis
In vitro hemolytic activity on human erythrocytes
was determined using grandiflorenic acid at concentrations
of 1, 2, 4, 6 and 8 µg/ml. None of the doses of grandiflorenic
acid possessed hemolytic activity against human RBC upto
24 h.
4. Discussion
In vitro cytotoxicity tests are based on the idea that
toxic  chemicals  affect  basic  cellular  functions  that  are
common to all cells, and that the toxicity can be measured by
assessing cellular damage. Early screening of compounds for
toxicity can help for identification as to whether they can be
further utilized for evaluating biological activity (Barile et al.,
1994). The grandiflorenic acid did not produce any cyto-
toxicity when treated with BJ human fibroblast, keratinocytes
HaCaT and Raw 264.7 macrophage cells. Previous reports
have  suggested  that  terpenoids  stimulated  the  growth  of
fibroblasts (Adetutu et al., 2011). The results obtained from
ent-kaura-9(11), 16-dien-19-oic acid (grandiflorenic acid),
a diterpene from W. trilobata, also support the scientific
findings.
The fibroblast is the connective tissue cell responsible
for  collagen  deposition  that  is  needed  to  repair  the  tissue
injury. In normal tissues collagen provides strength, integrity
and structure. When tissues are disrupted following injury,
collagen is needed to repair the defect and restore anatomic
Figure 7. The effect of various concentrations of grandiflorenic acid on IL-1 production in Raw 264.7 cell lines after 24 h of culture.
Data expressed as mean ± s.d.,(n= 4).
Figure 8. The effect of various concentrations of grandiflorenic acid on TNF- production in Raw 264.7 cell lines after 24 h of culture.
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structure and function (Diegelmann and Evans, 2004). Early
in  the  proliferation  phase  fibroblast  activity  is  limited  to
cellular replication and migration. Around the third day after
wounding  the  growing  mass  of  fibroblast  cells  begin  to
synthesize  and  secrete  measurable  amount  of  collagen.
Collagen levels rise continually for approximately three weeks.
The amount of collagen secreted during this period deter-
mines  the  tensile  strength  of  the  wound.  An  increase  in
collagen production is an important factor for wound healing.
Type-I collagen is the main collagen of bone, skin, tendon
and newly healed wounds (Aramwit et al., 2009a). Proteo-
glycans are glycoproteins that have a core protein with one
or more covalently attached glycosaminoglycan (GAG) chains
such as chondroitin sulfate and dermatan sulfate. They are
widely distributed in skin and cartilage as a major component
of extracellular matrix (Perrimon and Bernfield, 2001). They
play a vital role in cell proliferation, migration and adhesion.
Most of the growth factors and cytokines that are involved
in wound healing are immobilized at the cell surface and in
extracellular matrix through proteoglycan binding (Pratibha
and Gupta, 2000).
In our study it was observed that the grandiflorenic
acid above 10 µg/mL was cytotoxic to the fibroblast cells.
The dose 10 and 5 µg/mL showed good viability and increase
in collagen content, which was more than that of negative
control. Further reduction of dose of grandiflorenic acid (2.5
and 1.25 µg/mL) the viability was increased (109 and 112%)
with significant increase in collagen content. Further reduc-
tion of dose of grandiflorenic acid showed good viability but
with reduced collagen content although that reduction was
not  greater  than  that  of  negative  control,  It  could  be
concluded that dose of 2.5 and 1.25 are optimum dose with
good viability and increased collagen content. The grandi-
florenic  acid  and  proteoglycan  showed  an  increase  in
collagen production as compared to negative control group.
The  production  of  collagen  with  grandiflorenic  acid  was
comparable to that produced by proteoglycan.
Wounds that alter the epithelia lining the body and
internal organs represent a potential threat to the integrity of
the organism. A rapid re-epithelialization provides a barrier
from the external environment and prevents pathogenic and
toxic insults. In the skin, re-epithelialization is accomplished
by the migration of epidermal cells, the keratinocytes, into the
wounds. It is defined as the reconstitution of an organized,
stratified, and squamous epithelium that permanently covers
the wound defect and restores functions. The regeneration of
a functional epidermis depends on the reconstitution of the
dermoepidermal junction (DEJ), which anchors the epidermis
to the dermis, and on the terminal differentiation of kerati-
nocytes  into  a  protective  cornified  layer  (Laplante  et  al.,
2001). Transforming growth factor- (TGF-) is a family of
multipotent growth factors involved in the regulation of cell
proliferation, adhesion, migration, differentiation, and extra-
cellular matrix deposition, and is therefore intimately involved
in  regulating  wound  healing  and  fibrotic  scar  formation
(Leask and Abraham, 2004). The three mammalian isoforms,
TGF- 1, 2, and 3, are structurally almost identical, and yet
they  play  an  important  role  in  a  number  of  biological
processes. This is evident in healing as manipulation of the
levels of the three TGF-s affect the extent of scar tissue
formation.  By  reducing  the  levels  of  TGF-1  and  2  with
neutralizing antibodies, or addition of TGF-3, suppression
of fibrosis and scar formation occurs in healing wounds
(O’Kane and Fergusson, 1997). Amjad et al (2007) reported
keratinocytes did not release detectable levels of TGF-1
until 40-hour incubation, and even then the levels were very
low (40 pg/mL). In contrast, keratinocytes released large
amounts  of  TGF-2  into  the  cultured  medium,  which
increased progressively reaching > 500 pg/mL by 50 hours,
but did not release detectable levels of TGF-3. TGF- is an
important regulator of the extracellular matrix (ECM), stimu-
lating fibroplasia and collagen deposition, inhibiting ECM
degrading  proteases  and  upregulating  the  synthesis  of
protease inhibitors. Since all these processes are integral to
wound  healing,  the  role  of  TGF- in  wound  healing  and
regulation of their activity is of major clinical significance
(O’Kane and Fergusson, 1997). However, grandiflorenic acid
did not show stimulatory activity on HaCaT keratinocytes
and on levels of TGF-2. It may act directly on fibroblast for
its wound-healing activity.
The spreading and migration capabilities of BJ human
fibroblast  and  keratinocytes  HaCaT  cells  were  assessed
using a scratch wound assay which measures the expansion
of a cell population on surfaces. One of the major advantages
of this method is that it mimics to some extent migration of
cells in vivo (Liang et al., 2007). To estimate the wound re-
epithelialization potential of a test substance and to have a
quality control for the assay, a positive control (standard) is
required. A number of growth factors and cytokines have
been reported to affect fibroblast and keratinocytes motility
directly or indirectly. Since the role of proteoglycan is similar
to epidermal growth factor, it was taken as a positive control.
Altogether, results obtained showed that the scratch
assay  is  a  convenient  and  inexpensive  tool  to  evaluate
wound-healing activity. The scratch assay covers the second
phase of wound healing characterized by a proliferation and
migration of either keratinocytes or fibroblasts (Schafer and
Werner, 2007; Gurtner et al., 2008). Although the scratch
assay cannot substitute for in vivo studies as a final proof for
promoting wound healing, this study confirms its usefulness
for gaining an insight into the potential of a compound to
repair  injured  dermis.  Fibroblasts,  which  are  known  to  be
involved in granulation and collagen metabolism, are stimu-
lated by the grandiflorenic acid resulting in proliferation and
migration within the wound site. The grandiflorenic acid
seems not to act through keratinocytes stimulation as evident
from the data showing no proliferation and migration within
the wound site.
Nitric oxide is usually produced during inflammatory
conditions such as wound healing by the inducible isoform
of the enzyme NO synthase. Normally, large quantities of NO
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effects on various cellular functions that are linked to cGMP.
However,  lower  concentrations  of  NO  can  be  potentially
beneficial.  In  the  presence  of  low  concentrations  of  NO,
fibroblast  collagen  synthesis  together  with  total  protein
synthesis is enhanced, and this increase is independent of
the collagenase pathway (Aramwit et al., 2009b). Production
of  NO  by  Raw  264.7  cells  exposed  to  grandiflorenic  acid
could not be detected in culture supernatants.
The  Raw  264.7  cells  are  phagocytic  cells  playing
important roles in defense. They undergo increased oxidative
metabolism and release inflammatory cytokines (IL-1 or
TNF-) following their activation by phagocytosis (Shah et
al., 2002). These cytokines are involved in a variety of immu-
nological  functions  as  well  as  interactions  with  variety  of
target cells. It is widely accepted that IL-1, which is constitu-
tively  expressed  in  keratinocytes  and  accumulates  in  all
epidermal layers, is a very important inflammatory mediator
in  the  skin,  and  it  is  believed  to  be  the  main  switch  that
initiates  the  inflammatory  response.  TNF- is  another
proinflammatory cytokine that induces the expression of
cutaneous and endothelial adhesion molecules to develop
skin  irritation  and  inflammatory  responses.  It  is  stored  in
epidermal mast cells and is also expressed by keratinocytes
in response to irritation. The expression of TNF- is tran-
siently induced after treatment with various irritants and is
independent of release of IL-1. Both IL-1 and TNF- are
first response cytokines, which initiate a cascade of events
involving other second response cytokines, ultimately lead-
ing to inflammation. Previous studies have reported that IL-1
 and TNF- at concentration less than 100 ng/ml are not
toxic to keratinocytes (Aramwit et al., 2009b). The grandi-
florenic acid did not cause the Raw 264.7 cells to produce
toxic cytokines and NO at a level that would cascade to other
inflammatory  mediators  thereby  reducing  prolongation  of
inflammatory phase of wound healing.
Hemolytic assay was performed because compounds
possessing  wound-healing  activity  may  not  be  useful  in
pharmacological  preparations  for  open  wounds  if  they
possess  hemolytic  effect.  Results  showed  no  evidence  of
hemolysis with grandiflorenic acid upto 8 µg/ml. It showed
wound-healing activity at dose below 3 µg/ml and this dose
did not show any hemolysis. Thus, it should be possible to
use grandiflorenic acid for open and chronic wounds.
5. Conclusion
The present study provides scientific evidence that
grandiflorenic acid has potential wound-healing activity due
to a combination of fibroblast and macrophage stimulating
activity. It can be used as a monotherapeutic wound healing
agent or may be combined with other wound-healing agent
for synergistic effects.
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